Hjem › Medulloblastom
Medulloblastom kliniske forsøg rekrutterer i USA
24 studier for Medulloblastom rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Washington, DC9 studier
- St. Louis, MO6 studier
- Houston, TX4 studier
- New York City, NY4 studier
- Philadelphia, PA4 studier
- Durham, NC4 studier
- Miami, FL4 studier
- Seattle, WA4 studier
- Tampa, FL4 studier
- Memphis, TN3 studier
- Columbus, OH3 studier
- Ann Arbor, MI3 studier
- Chicago, IL3 studier
- Boston, MA3 studier
- Cincinnati, OH3 studier
- Little Rock, AR3 studier
- Dallas, TX3 studier
- Charlotte, NC3 studier
- Orlando, FL3 studier
- San Francisco, CA3 studier
- San Diego, CA3 studier
- Minneapolis, MN3 studier
- Austin, TX3 studier
- St. Petersburg, FL3 studier
- Hartford, CT3 studier
- Mountain View, CA3 studier
Efter delstat
- Alabama3 studier
- Arkansas3 studier
- Californien6 studier
- Connecticut3 studier
- District of Columbia7 studier
- Florida6 studier
- Georgia3 studier
- Illinois3 studier
- Kentucky3 studier
- Maryland4 studier
- Massachusetts3 studier
- Michigan4 studier
- Minnesota3 studier
- Missouri6 studier
- New Jersey3 studier
- New York5 studier
- North Carolina4 studier
- Ohio3 studier
- Pennsylvania5 studier
- Tennessee5 studier
- Texas8 studier
- Washington4 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
RekruttererFase 1/2
Alder 1 til 25 · Alle køn · Opdateret 28. sep. 2026 · NCT07346157Cognitive Rehabilitation for Survivors of Childhood Medulloblastoma Using Real Time Hemodynamic Neurofeedback
Rekrutterer
Alder 10 til 25 · Alle køn · Opdateret 23. sep. 2026 · NCT07830134Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
RekruttererFase 2
59 Months · Alle køn · Opdateret 15. sep. 2026 · NCT05535166GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
RekruttererFase 1
Alder 1 til 30 · Alle køn · Opdateret 11. sep. 2026 · NCT07087002Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
RekruttererFase 2
Op til 19 år · Alle køn · Opdateret 10. sep. 2026 · NCT01356290HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RekruttererFase 1
36 Months – 22 Years · Alle køn · Opdateret 4. sep. 2026 · NCT03911388B7-H3.CD28Z.CART in CNS Neoplasms
RekruttererFase 1
Alder 2 til 21 · Alle køn · Opdateret 3. sep. 2026 · NCT07390539Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
RekruttererObservationsstudie
Alder 3 til 50 · Alle køn · Opdateret 1. sep. 2026 · NCT07242963Digoxin Medulloblastoma Study
RekruttererFase 2
12 Months – 30 Years · Alle køn · Opdateret 26. aug. 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
RekruttererFase 3
Alder 4 til 21 · Alle køn · Opdateret 25. aug. 2026 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RekruttererFase 2
Alder 3 til 39 · Alle køn · Opdateret 24. aug. 2026 · NCT05096481PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
RekruttererFase 1/2
Alder 18 til 120 · Alle køn · Opdateret 12. aug. 2026 · NCT06161519DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
RekruttererFase 2
Op til 21 år · Alle køn · Opdateret 12. aug. 2026 · NCT04696029Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
Rekrutterer
12 Months – 39 Years · Alle køn · Opdateret 11. aug. 2026 · NCT05057702Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
RekruttererFase 1
Alder 4 til 30 · Alle køn · Opdateret 7. aug. 2026 · NCT06514898Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
RekruttererFase 1
Alder 2 til 25 · Alle køn · Opdateret 3. aug. 2026 · NCT06624371Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
RekruttererFase 1/2
Alder 4 til 39 · Alle køn · Opdateret 20. jul. 2026 · NCT05278208A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)
RekruttererFase 1
Alder 3 til 22 · Alle køn · Opdateret 13. jul. 2026 · NCT07698899CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 6. jul. 2026 · NCT07085325Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
RekruttererFase 1
Alder 1 til 30 · Alle køn · Opdateret 17. jun. 2026 · NCT06193759Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
RekruttererFase 1
Alder 1 til 26 · Alle køn · Opdateret 13. apr. 2026 · NCT04185038Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
RekruttererFase 1
Alder 3 til 25 · Alle køn · Opdateret 9. jan. 2026 · NCT05106296Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 18. dec. 2025 · NCT0454108268-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
RekruttererFase 4
Alder 18 til 100 · Alle køn · Opdateret 21. nov. 2025 · NCT04081701Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.